使B

Cristina Jiménez1, Alba Garrote-de-Barros2,3, Carlos López-Portugués4,5

  • 1Hematology Department, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), 37007 Salamanca, Spain.

概括

这篇评论探讨了B细胞恶性瘤,包括白血病,骨髓瘤和淋巴瘤. 蛋白质组学策略被强调为分析这些疾病和识别诊断生物标志物的关键工具.